What are Gonadotropin combination drugs?

Gonadotropin combination drugs are pharmacologic agents that share a common mechanism (typically targeting FSH receptor, LH receptor). 1 are currently marketed, with 2 more in clinical development.

What are the marketed Gonadotropin combination drugs?

Marketed Gonadotropin combination drugs include r-FSH plus HP-hMG.

Gonadotropin combination

1 marketed 2 in Phase 3

This page covers all Gonadotropin combination drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting FSH receptor, LH receptor, FSH receptor (FSHR) and LH receptor (LHCGR), FSH receptor and hCG receptor (LH/hCG receptor).

Targets

FSH receptor, LH receptor · FSH receptor (FSHR) and LH receptor (LHCGR) · FSH receptor and hCG receptor (LH/hCG receptor)

Marketed (1)

r-FSH plus HP-hMG · Instituto Valenciano de Infertilidad, IVI VALENCIA · Reproductive Medicine / Fertility
A combination of recombinant follicle-stimulating hormone (r-FSH) and highly purified human menopausal gonadotropin (HP-hMG) that stimulates ovarian follicle development and hormone production for assisted reproductive technology.

Phase 3 pipeline (2)

FSH+LH · Instituto Valenciano de Infertilidad, IVI VALENCIA · Reproductive Medicine / Infertility
FSH and LH are gonadotropins that stimulate follicle development and ovulation in women, used to induce ovarian stimulation for assisted reproductive technologies.
Low dose hCG plus FSH co-trigger · University of California, San Francisco · Reproductive Medicine / Fertility
Low-dose hCG combined with FSH acts as a dual trigger to induce final oocyte maturation and ovulation in assisted reproductive technology cycles.